MGMT Promoter Methylation and IDH1 Mutation Testing to Prognosticate Glioblastoma Multiforme and Determine Alkylating Agent Treatment Eligibility: KHCC Experience

被引：0
|
作者：
Naser, W. [1 ]
Muhsen, B. [1 ]
Al-Hussaini, M. [1 ]
Abu Aboud, R. [1 ]
Al Masri, M. [1 ]
Amarin, R. [1 ]
Abu Laban, D. [1 ]
Tbakhi, A. [1 ]
机构：
[1] King Hussein Canc Ctr, Amman, Jordan
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2022年 / 24卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
TT005
引用
收藏
页码：S131 / S132
页数：2
相关论文
共 30 条
  • [1] Perampanel in the Treatment of a Patient with Glioblastoma Multiforme without IDH1 Mutation and without MGMT Promotor Methylation
    Roesche, J.
    Piek, J.
    Hildebrandt, G.
    Grossmann, A.
    Kirschstein, T.
    Benecke, R.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2015, 83 (05) : 286 - 289
  • [2] MGMT promoter methylation and IDH1 mutation as prognostic markers for a favorable clinical outcome in patients with glioblastoma multiforme.
    Wozniak, A.
    Van Mieghem, E.
    Ardon, H.
    De Vleeschouwer, S.
    Menten, J.
    Sciot, R.
    Van Calenbergh, F.
    Van Gool, S.
    Debiec-Rychter, M.
    Clement, P. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] The Analysis of IDH1 Mutation and MGMT Promoter Methylation in Malignant Gliomas
    Takahashi, Yoshinobu
    Nakamura, Hideo
    Makino, Keishi
    Hide, Takuichirou
    Muta, Daisuke
    Kuratsu, Jun-ichi
    JOURNAL OF NEUROSURGERY, 2012, 117 (02) : A445 - A445
  • [4] XGBoost Improves Classification of MGMT Promoter Methylation Status in IDH1 Wildtype Glioblastoma
    Le, Nguyen Quoc Khanh
    Do, Duyen Thi
    Chiu, Fang-Ying
    Yapp, Edward Kien Yee
    Yeh, Hui-Yuan
    Chen, Cheng-Yu
    JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (03): : 1 - 13
  • [5] Prognosis of Glioblastoma With Oligodendroglioma Component is Associated With the IDH1 Mutation and MGMT Methylation Status
    Myung, Jae Kyung
    Cho, Hwa Jin
    Kim, Hanna
    Park, Chul-Kee
    Lee, Se Hoon
    Choi, Seung Hong
    Park, Peom
    Yoon, Jung Min
    Park, Sung-Hye
    TRANSLATIONAL ONCOLOGY, 2014, 7 (06): : 712 - 719
  • [6] Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation
    Wick, Wolfgang
    Meisner, Christoph
    Hentschel, Bettina
    Platten, Michael
    Schilling, Alissa
    Wiestler, Benedikt
    Sabel, Michael C.
    Koeppen, Susanne
    Ketter, Ralf
    Weiler, Markus
    Tabatabai, Ghazaleh
    von Deimling, Andreas
    Gramatzki, Dorothee
    Westphal, Manfred
    Schackert, Gabriele
    Loeffler, Markus
    Simon, Matthias
    Reifenberger, Guido
    Weller, Michael
    NEUROLOGY, 2013, 81 (17) : 1515 - 1522
  • [7] The association between IDH1 mutation and MGMT promoter methylation in Indonesian glioma patients
    Hudiana, Dina
    Malueka, Rusdy
    Dananjoyo, Kusumo
    Asmedi, Ahmad
    Dwianingsih, Ery Kus
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [8] Identification of MGMT promoter methylation sites correlating with gene expression and IDH1 mutation in gliomas
    Zhang, Jie
    Yang, Jian-hui
    Quan, Jia
    Kang, Xing
    Wang, Hui-juan
    Dai, Peng-gao
    TUMOR BIOLOGY, 2016, 37 (10) : 13571 - 13579
  • [9] Prognostic Significance of IDH1/2 Mutation and MGMT Promoter Methylation Status in RTOG 9813
    Fleming, J. L.
    Pugh, S.
    Bell, E. H.
    Chang, S. M.
    McElroy, J.
    Becker, A.
    Timmers, C. D.
    Shih, H. A.
    Ashby, L.
    Hunter, G. K.
    Bahary, J. P.
    Schultz, C. J.
    Kavanagh, B. D.
    Yung, W. A.
    Robins, I.
    Werner-Wasik, M.
    Chakravarti, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (05): : 1399 - 1399
  • [10] Prognostic Value of MGMT Promoter Methylation and TP53 Mutation in Glioblastomas Depends on IDH1 Mutation
    Wang, Kai
    Wang, Yin-Yan
    Ma, Jun
    Wang, Jiang-Fei
    Li, Shao-Wu
    Jiang, Tao
    Dai, Jian-Ping
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (24) : 10893 - 10898
123